Alagon, Alona C.

HRN: 25-58-74  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/31/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/30/2024
07/30/2024
IV INFUSION
4.5g
LD
Urosepsis
Waiting Final Action 
07/31/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/30/2024
08/06/2024
IV INFUSION
2.25gm
Q8H
Urosepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: